nodes	percent_of_prediction	percent_of_DWPC	metapath
Tramadol—restless legs syndrome—Gabapentin—migraine	0.325	1	CpDpCtD
Tramadol—HTR2C—migraine	0.145	0.547	CbGaD
Tramadol—SLC6A4—migraine	0.121	0.453	CbGaD
Tramadol—OPRD1—Amitriptyline—migraine	0.0371	0.139	CbGbCtD
Tramadol—OPRK1—Amitriptyline—migraine	0.0311	0.117	CbGbCtD
Tramadol—OPRM1—Amitriptyline—migraine	0.0274	0.103	CbGbCtD
Tramadol—SLC6A4—Amitriptyline—migraine	0.0226	0.085	CbGbCtD
Tramadol—CHRM3—Amitriptyline—migraine	0.0194	0.0729	CbGbCtD
Tramadol—SLC6A2—Amitriptyline—migraine	0.0189	0.0711	CbGbCtD
Tramadol—HTR2C—Amitriptyline—migraine	0.0189	0.0711	CbGbCtD
Tramadol—SLC6A4—Verapamil—migraine	0.018	0.0675	CbGbCtD
Tramadol—CYP2B6—Amitriptyline—migraine	0.0117	0.0441	CbGbCtD
Tramadol—CYP2B6—Valproic Acid—migraine	0.0107	0.0402	CbGbCtD
Tramadol—CYP2B6—Verapamil—migraine	0.00932	0.035	CbGbCtD
Tramadol—CYP2D6—Timolol—migraine	0.00736	0.0277	CbGbCtD
Tramadol—CYP2D6—Propranolol—migraine	0.00656	0.0246	CbGbCtD
Tramadol—CYP2D6—Amitriptyline—migraine	0.00568	0.0213	CbGbCtD
Tramadol—CYP2D6—Verapamil—migraine	0.0045	0.0169	CbGbCtD
Tramadol—CYP3A4—Propranolol—migraine	0.00417	0.0157	CbGbCtD
Tramadol—CYP3A4—Amitriptyline—migraine	0.00361	0.0136	CbGbCtD
Tramadol—CYP3A4—Valproic Acid—migraine	0.00329	0.0124	CbGbCtD
Tramadol—CYP3A4—Topiramate—migraine	0.00297	0.0111	CbGbCtD
Tramadol—CYP3A4—Verapamil—migraine	0.00286	0.0108	CbGbCtD
Tramadol—SLC6A2—locus ceruleus—migraine	0.00193	0.133	CbGeAlD
Tramadol—SLC6A2—sympathetic nervous system—migraine	0.00153	0.105	CbGeAlD
Tramadol—SLC6A2—autonomic nervous system—migraine	0.00103	0.0708	CbGeAlD
Tramadol—Venlafaxine—SLC6A4—migraine	0.000858	0.696	CrCbGaD
Tramadol—OPRM1—nerve—migraine	0.000788	0.0544	CbGeAlD
Tramadol—SLC6A2—nerve—migraine	0.000577	0.0398	CbGeAlD
Tramadol—GRIN3A—head—migraine	0.000389	0.0268	CbGeAlD
Tramadol—Dextromethorphan—SLC6A4—migraine	0.000376	0.305	CrCbGaD
Tramadol—GRIN3A—nervous system—migraine	0.000369	0.0254	CbGeAlD
Tramadol—GRIN3A—central nervous system—migraine	0.000355	0.0245	CbGeAlD
Tramadol—OPRM1—brainstem—migraine	0.000338	0.0233	CbGeAlD
Tramadol—HTR2C—brainstem—migraine	0.000297	0.0205	CbGeAlD
Tramadol—GRIN3A—brain—migraine	0.000282	0.0195	CbGeAlD
Tramadol—SLC6A4—brainstem—migraine	0.000281	0.0194	CbGeAlD
Tramadol—OPRD1—head—migraine	0.000274	0.0189	CbGeAlD
Tramadol—OPRK1—head—migraine	0.000263	0.0181	CbGeAlD
Tramadol—OPRD1—nervous system—migraine	0.00026	0.0179	CbGeAlD
Tramadol—OPRD1—central nervous system—migraine	0.00025	0.0173	CbGeAlD
Tramadol—OPRK1—nervous system—migraine	0.000249	0.0172	CbGeAlD
Tramadol—SLC6A2—brainstem—migraine	0.000248	0.0171	CbGeAlD
Tramadol—OPRK1—central nervous system—migraine	0.00024	0.0165	CbGeAlD
Tramadol—OPRK1—cerebellum—migraine	0.000234	0.0162	CbGeAlD
Tramadol—OPRD1—brain—migraine	0.000199	0.0137	CbGeAlD
Tramadol—OPRK1—brain—migraine	0.00019	0.0131	CbGeAlD
Tramadol—OPRM1—head—migraine	0.000187	0.0129	CbGeAlD
Tramadol—OPRM1—nervous system—migraine	0.000177	0.0122	CbGeAlD
Tramadol—OPRM1—central nervous system—migraine	0.000171	0.0118	CbGeAlD
Tramadol—HTR2C—head—migraine	0.000164	0.0113	CbGeAlD
Tramadol—HTR2C—nervous system—migraine	0.000155	0.0107	CbGeAlD
Tramadol—SLC6A4—head—migraine	0.000155	0.0107	CbGeAlD
Tramadol—HTR2C—central nervous system—migraine	0.00015	0.0103	CbGeAlD
Tramadol—CYP2B6—cardiovascular system—migraine	0.000149	0.0103	CbGeAlD
Tramadol—SLC6A4—nervous system—migraine	0.000147	0.0102	CbGeAlD
Tramadol—SLC6A4—central nervous system—migraine	0.000142	0.00979	CbGeAlD
Tramadol—CHRM3—head—migraine	0.000139	0.00956	CbGeAlD
Tramadol—SLC6A2—head—migraine	0.000137	0.00944	CbGeAlD
Tramadol—CYP2D6—brainstem—migraine	0.000136	0.00936	CbGeAlD
Tramadol—OPRM1—brain—migraine	0.000135	0.00935	CbGeAlD
Tramadol—CHRM3—nervous system—migraine	0.000131	0.00907	CbGeAlD
Tramadol—SLC6A2—nervous system—migraine	0.00013	0.00895	CbGeAlD
Tramadol—CHRM3—central nervous system—migraine	0.000126	0.00873	CbGeAlD
Tramadol—SLC6A2—central nervous system—migraine	0.000125	0.00862	CbGeAlD
Tramadol—HTR2C—brain—migraine	0.000119	0.0082	CbGeAlD
Tramadol—SLC6A4—brain—migraine	0.000113	0.00777	CbGeAlD
Tramadol—CYP2B6—head—migraine	0.000101	0.00696	CbGeAlD
Tramadol—CHRM3—brain—migraine	0.0001	0.00693	CbGeAlD
Tramadol—SLC6A2—brain—migraine	9.91e-05	0.00684	CbGeAlD
Tramadol—CYP2B6—nervous system—migraine	9.56e-05	0.0066	CbGeAlD
Tramadol—CYP2B6—central nervous system—migraine	9.2e-05	0.00635	CbGeAlD
Tramadol—CYP2D6—head—migraine	7.49e-05	0.00517	CbGeAlD
Tramadol—CYP2B6—brain—migraine	7.31e-05	0.00504	CbGeAlD
Tramadol—CYP3A4—nervous system—migraine	7.22e-05	0.00498	CbGeAlD
Tramadol—CYP2D6—nervous system—migraine	7.1e-05	0.0049	CbGeAlD
Tramadol—CYP3A4—central nervous system—migraine	6.95e-05	0.0048	CbGeAlD
Tramadol—CYP2D6—central nervous system—migraine	6.84e-05	0.00472	CbGeAlD
Tramadol—CYP2D6—cerebellum—migraine	6.68e-05	0.00461	CbGeAlD
Tramadol—CYP2D6—brain—migraine	5.43e-05	0.00375	CbGeAlD
Tramadol—Erythema—Gabapentin—migraine	3.74e-05	0.000388	CcSEcCtD
Tramadol—Dizziness—Propranolol—migraine	3.73e-05	0.000387	CcSEcCtD
Tramadol—Asthenia—Verapamil—migraine	3.73e-05	0.000386	CcSEcCtD
Tramadol—Confusional state—Valproic Acid—migraine	3.71e-05	0.000385	CcSEcCtD
Tramadol—Flatulence—Gabapentin—migraine	3.69e-05	0.000382	CcSEcCtD
Tramadol—Anaphylactic shock—Valproic Acid—migraine	3.68e-05	0.000382	CcSEcCtD
Tramadol—Bradycardia—Topiramate—migraine	3.68e-05	0.000382	CcSEcCtD
Tramadol—Pruritus—Verapamil—migraine	3.67e-05	0.000381	CcSEcCtD
Tramadol—Tension—Gabapentin—migraine	3.67e-05	0.000381	CcSEcCtD
Tramadol—Angioedema—Timolol—migraine	3.67e-05	0.000381	CcSEcCtD
Tramadol—Dysgeusia—Gabapentin—migraine	3.66e-05	0.00038	CcSEcCtD
Tramadol—Infection—Valproic Acid—migraine	3.66e-05	0.000379	CcSEcCtD
Tramadol—Haemoglobin—Topiramate—migraine	3.63e-05	0.000377	CcSEcCtD
Tramadol—Nervousness—Gabapentin—migraine	3.63e-05	0.000377	CcSEcCtD
Tramadol—Rhinitis—Topiramate—migraine	3.62e-05	0.000376	CcSEcCtD
Tramadol—Back pain—Gabapentin—migraine	3.62e-05	0.000375	CcSEcCtD
Tramadol—Haemorrhage—Topiramate—migraine	3.61e-05	0.000375	CcSEcCtD
Tramadol—Hepatitis—Topiramate—migraine	3.61e-05	0.000375	CcSEcCtD
Tramadol—Nervous system disorder—Valproic Acid—migraine	3.61e-05	0.000375	CcSEcCtD
Tramadol—Vertigo—Timolol—migraine	3.61e-05	0.000374	CcSEcCtD
Tramadol—Thrombocytopenia—Valproic Acid—migraine	3.61e-05	0.000374	CcSEcCtD
Tramadol—Syncope—Timolol—migraine	3.6e-05	0.000374	CcSEcCtD
Tramadol—Hallucination—Topiramate—migraine	3.6e-05	0.000373	CcSEcCtD
Tramadol—Hypoaesthesia—Topiramate—migraine	3.6e-05	0.000373	CcSEcCtD
Tramadol—Muscle spasms—Gabapentin—migraine	3.6e-05	0.000373	CcSEcCtD
Tramadol—Tachycardia—Valproic Acid—migraine	3.59e-05	0.000373	CcSEcCtD
Tramadol—Vomiting—Propranolol—migraine	3.59e-05	0.000372	CcSEcCtD
Tramadol—Pharyngitis—Topiramate—migraine	3.59e-05	0.000372	CcSEcCtD
Tramadol—Skin disorder—Valproic Acid—migraine	3.58e-05	0.000371	CcSEcCtD
Tramadol—Urinary tract disorder—Topiramate—migraine	3.57e-05	0.00037	CcSEcCtD
Tramadol—Oedema peripheral—Topiramate—migraine	3.56e-05	0.000369	CcSEcCtD
Tramadol—Hyperhidrosis—Valproic Acid—migraine	3.56e-05	0.000369	CcSEcCtD
Tramadol—Rash—Propranolol—migraine	3.56e-05	0.000369	CcSEcCtD
Tramadol—Dermatitis—Propranolol—migraine	3.56e-05	0.000369	CcSEcCtD
Tramadol—Diarrhoea—Verapamil—migraine	3.55e-05	0.000369	CcSEcCtD
Tramadol—Connective tissue disorder—Topiramate—migraine	3.55e-05	0.000368	CcSEcCtD
Tramadol—Palpitations—Timolol—migraine	3.55e-05	0.000368	CcSEcCtD
Tramadol—Urethral disorder—Topiramate—migraine	3.54e-05	0.000368	CcSEcCtD
Tramadol—OPRM1—GPCR ligand binding—TAC1—migraine	3.53e-05	0.00116	CbGpPWpGaD
Tramadol—OPRM1—GPCR ligand binding—NPS—migraine	3.53e-05	0.00116	CbGpPWpGaD
Tramadol—Loss of consciousness—Timolol—migraine	3.53e-05	0.000366	CcSEcCtD
Tramadol—Vision blurred—Gabapentin—migraine	3.52e-05	0.000366	CcSEcCtD
Tramadol—Anorexia—Valproic Acid—migraine	3.51e-05	0.000364	CcSEcCtD
Tramadol—Cough—Timolol—migraine	3.5e-05	0.000364	CcSEcCtD
Tramadol—Tremor—Gabapentin—migraine	3.5e-05	0.000363	CcSEcCtD
Tramadol—Visual impairment—Topiramate—migraine	3.48e-05	0.000361	CcSEcCtD
Tramadol—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	3.48e-05	0.00114	CbGpPWpGaD
Tramadol—OPRM1—GPCR downstream signaling—HTR1D—migraine	3.47e-05	0.00114	CbGpPWpGaD
Tramadol—Ill-defined disorder—Gabapentin—migraine	3.47e-05	0.00036	CcSEcCtD
Tramadol—OPRK1—Signaling by GPCR—HTR2B—migraine	3.47e-05	0.00114	CbGpPWpGaD
Tramadol—Hypertension—Timolol—migraine	3.47e-05	0.00036	CcSEcCtD
Tramadol—OPRM1—GPCR ligand binding—HTR2C—migraine	3.46e-05	0.00114	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—CALCRL—migraine	3.46e-05	0.00114	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—RAMP1—migraine	3.46e-05	0.00114	CbGpPWpGaD
Tramadol—Anaemia—Gabapentin—migraine	3.46e-05	0.000359	CcSEcCtD
Tramadol—Hypotension—Valproic Acid—migraine	3.44e-05	0.000357	CcSEcCtD
Tramadol—Agitation—Gabapentin—migraine	3.44e-05	0.000356	CcSEcCtD
Tramadol—CHRM3—GPCRs, Class A Rhodopsin-like—HTR7—migraine	3.44e-05	0.00113	CbGpPWpGaD
Tramadol—Dizziness—Verapamil—migraine	3.43e-05	0.000356	CcSEcCtD
Tramadol—CHRM3—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	3.43e-05	0.00113	CbGpPWpGaD
Tramadol—CHRM3—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	3.43e-05	0.00113	CbGpPWpGaD
Tramadol—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	3.42e-05	0.00112	CbGpPWpGaD
Tramadol—Arthralgia—Timolol—migraine	3.42e-05	0.000355	CcSEcCtD
Tramadol—Myalgia—Timolol—migraine	3.42e-05	0.000355	CcSEcCtD
Tramadol—Chest pain—Timolol—migraine	3.42e-05	0.000355	CcSEcCtD
Tramadol—Erythema multiforme—Topiramate—migraine	3.42e-05	0.000354	CcSEcCtD
Tramadol—Angioedema—Gabapentin—migraine	3.42e-05	0.000354	CcSEcCtD
Tramadol—Anxiety—Timolol—migraine	3.41e-05	0.000353	CcSEcCtD
Tramadol—Unspecified disorder of skin and subcutaneous tissue—Timolol—migraine	3.4e-05	0.000352	CcSEcCtD
Tramadol—Discomfort—Timolol—migraine	3.38e-05	0.00035	CcSEcCtD
Tramadol—Eye disorder—Topiramate—migraine	3.38e-05	0.00035	CcSEcCtD
Tramadol—Malaise—Gabapentin—migraine	3.37e-05	0.00035	CcSEcCtD
Tramadol—Tinnitus—Topiramate—migraine	3.37e-05	0.00035	CcSEcCtD
Tramadol—OPRM1—GPCR ligand binding—EDNRA—migraine	3.37e-05	0.00111	CbGpPWpGaD
Tramadol—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	3.36e-05	0.0011	CbGpPWpGaD
Tramadol—Vertigo—Gabapentin—migraine	3.36e-05	0.000349	CcSEcCtD
Tramadol—Musculoskeletal discomfort—Valproic Acid—migraine	3.35e-05	0.000348	CcSEcCtD
Tramadol—Flushing—Topiramate—migraine	3.35e-05	0.000348	CcSEcCtD
Tramadol—Cardiac disorder—Topiramate—migraine	3.35e-05	0.000348	CcSEcCtD
Tramadol—Syncope—Gabapentin—migraine	3.35e-05	0.000348	CcSEcCtD
Tramadol—Nausea—Propranolol—migraine	3.35e-05	0.000348	CcSEcCtD
Tramadol—Dry mouth—Timolol—migraine	3.34e-05	0.000347	CcSEcCtD
Tramadol—Insomnia—Valproic Acid—migraine	3.33e-05	0.000345	CcSEcCtD
Tramadol—Paraesthesia—Valproic Acid—migraine	3.31e-05	0.000343	CcSEcCtD
Tramadol—Palpitations—Gabapentin—migraine	3.31e-05	0.000343	CcSEcCtD
Tramadol—Confusional state—Timolol—migraine	3.3e-05	0.000343	CcSEcCtD
Tramadol—Vomiting—Verapamil—migraine	3.3e-05	0.000342	CcSEcCtD
Tramadol—OPRK1—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	3.3e-05	0.00108	CbGpPWpGaD
Tramadol—Loss of consciousness—Gabapentin—migraine	3.29e-05	0.000341	CcSEcCtD
Tramadol—Dyspnoea—Valproic Acid—migraine	3.28e-05	0.00034	CcSEcCtD
Tramadol—Angiopathy—Topiramate—migraine	3.28e-05	0.00034	CcSEcCtD
Tramadol—Anaphylactic shock—Timolol—migraine	3.28e-05	0.00034	CcSEcCtD
Tramadol—Rash—Verapamil—migraine	3.27e-05	0.00034	CcSEcCtD
Tramadol—Somnolence—Valproic Acid—migraine	3.27e-05	0.00034	CcSEcCtD
Tramadol—Dermatitis—Verapamil—migraine	3.27e-05	0.000339	CcSEcCtD
Tramadol—CHRM3—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	3.27e-05	0.00107	CbGpPWpGaD
Tramadol—Immune system disorder—Topiramate—migraine	3.26e-05	0.000339	CcSEcCtD
Tramadol—Cough—Gabapentin—migraine	3.26e-05	0.000339	CcSEcCtD
Tramadol—Mediastinal disorder—Topiramate—migraine	3.26e-05	0.000338	CcSEcCtD
Tramadol—Infection—Timolol—migraine	3.26e-05	0.000338	CcSEcCtD
Tramadol—OPRM1—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	3.26e-05	0.00107	CbGpPWpGaD
Tramadol—Headache—Verapamil—migraine	3.25e-05	0.000337	CcSEcCtD
Tramadol—Chills—Topiramate—migraine	3.24e-05	0.000336	CcSEcCtD
Tramadol—OPRM1—GPCR ligand binding—CALCA—migraine	3.24e-05	0.00106	CbGpPWpGaD
Tramadol—Dyspepsia—Valproic Acid—migraine	3.24e-05	0.000336	CcSEcCtD
Tramadol—Convulsion—Gabapentin—migraine	3.24e-05	0.000336	CcSEcCtD
Tramadol—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—migraine	3.23e-05	0.00106	CbGpPWpGaD
Tramadol—OPRM1—GPCR downstream signaling—HTR2B—migraine	3.23e-05	0.00106	CbGpPWpGaD
Tramadol—Hypertension—Gabapentin—migraine	3.23e-05	0.000335	CcSEcCtD
Tramadol—Shock—Timolol—migraine	3.22e-05	0.000334	CcSEcCtD
Tramadol—Nervous system disorder—Timolol—migraine	3.21e-05	0.000333	CcSEcCtD
Tramadol—CHRM3—Signaling by GPCR—CALCRL—migraine	3.21e-05	0.00105	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—RAMP1—migraine	3.21e-05	0.00105	CbGpPWpGaD
Tramadol—Decreased appetite—Valproic Acid—migraine	3.2e-05	0.000332	CcSEcCtD
Tramadol—HTR2C—GPCR ligand binding—HTR1B—migraine	3.2e-05	0.00105	CbGpPWpGaD
Tramadol—Arthralgia—Gabapentin—migraine	3.18e-05	0.00033	CcSEcCtD
Tramadol—Chest pain—Gabapentin—migraine	3.18e-05	0.00033	CcSEcCtD
Tramadol—Myalgia—Gabapentin—migraine	3.18e-05	0.00033	CcSEcCtD
Tramadol—Skin disorder—Timolol—migraine	3.18e-05	0.00033	CcSEcCtD
Tramadol—Gastrointestinal disorder—Valproic Acid—migraine	3.18e-05	0.00033	CcSEcCtD
Tramadol—Fatigue—Valproic Acid—migraine	3.17e-05	0.000329	CcSEcCtD
Tramadol—Anxiety—Gabapentin—migraine	3.17e-05	0.000329	CcSEcCtD
Tramadol—Hyperhidrosis—Timolol—migraine	3.17e-05	0.000329	CcSEcCtD
Tramadol—Mental disorder—Topiramate—migraine	3.17e-05	0.000328	CcSEcCtD
Tramadol—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—migraine	3.16e-05	0.000328	CcSEcCtD
Tramadol—OPRM1—Signaling by GPCR—HTR1D—migraine	3.15e-05	0.00104	CbGpPWpGaD
Tramadol—Pain—Valproic Acid—migraine	3.15e-05	0.000327	CcSEcCtD
Tramadol—Constipation—Valproic Acid—migraine	3.15e-05	0.000327	CcSEcCtD
Tramadol—Erythema—Topiramate—migraine	3.15e-05	0.000326	CcSEcCtD
Tramadol—Malnutrition—Topiramate—migraine	3.15e-05	0.000326	CcSEcCtD
Tramadol—Discomfort—Gabapentin—migraine	3.15e-05	0.000326	CcSEcCtD
Tramadol—Anorexia—Timolol—migraine	3.12e-05	0.000324	CcSEcCtD
Tramadol—Dry mouth—Gabapentin—migraine	3.11e-05	0.000323	CcSEcCtD
Tramadol—CHRM3—G alpha (q) signalling events—HTR2A—migraine	3.11e-05	0.00102	CbGpPWpGaD
Tramadol—Flatulence—Topiramate—migraine	3.1e-05	0.000322	CcSEcCtD
Tramadol—Tension—Topiramate—migraine	3.09e-05	0.00032	CcSEcCtD
Tramadol—Nausea—Verapamil—migraine	3.08e-05	0.00032	CcSEcCtD
Tramadol—Dysgeusia—Topiramate—migraine	3.08e-05	0.00032	CcSEcCtD
Tramadol—HTR2C—GPCR ligand binding—HTR1A—migraine	3.08e-05	0.00101	CbGpPWpGaD
Tramadol—Confusional state—Gabapentin—migraine	3.08e-05	0.000319	CcSEcCtD
Tramadol—Hypotension—Timolol—migraine	3.06e-05	0.000318	CcSEcCtD
Tramadol—Nervousness—Topiramate—migraine	3.06e-05	0.000317	CcSEcCtD
Tramadol—Anaphylactic shock—Gabapentin—migraine	3.05e-05	0.000317	CcSEcCtD
Tramadol—Back pain—Topiramate—migraine	3.04e-05	0.000316	CcSEcCtD
Tramadol—OPRK1—Signaling Pathways—RAMP1—migraine	3.03e-05	0.000996	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—CALCRL—migraine	3.03e-05	0.000996	CbGpPWpGaD
Tramadol—Feeling abnormal—Valproic Acid—migraine	3.03e-05	0.000315	CcSEcCtD
Tramadol—Infection—Gabapentin—migraine	3.03e-05	0.000315	CcSEcCtD
Tramadol—OPRM1—GPCR ligand binding—HTR7—migraine	3.03e-05	0.000996	CbGpPWpGaD
Tramadol—HTR2C—GPCR ligand binding—TAC1—migraine	3.03e-05	0.000996	CbGpPWpGaD
Tramadol—HTR2C—GPCR ligand binding—NPS—migraine	3.03e-05	0.000996	CbGpPWpGaD
Tramadol—Muscle spasms—Topiramate—migraine	3.03e-05	0.000314	CcSEcCtD
Tramadol—Gastrointestinal pain—Valproic Acid—migraine	3.01e-05	0.000312	CcSEcCtD
Tramadol—Shock—Gabapentin—migraine	3e-05	0.000311	CcSEcCtD
Tramadol—Nervous system disorder—Gabapentin—migraine	2.99e-05	0.00031	CcSEcCtD
Tramadol—Thrombocytopenia—Gabapentin—migraine	2.99e-05	0.00031	CcSEcCtD
Tramadol—Musculoskeletal discomfort—Timolol—migraine	2.99e-05	0.00031	CcSEcCtD
Tramadol—HTR2C—GPCR downstream signaling—HTR1D—migraine	2.98e-05	0.00098	CbGpPWpGaD
Tramadol—Tachycardia—Gabapentin—migraine	2.98e-05	0.000309	CcSEcCtD
Tramadol—Vision blurred—Topiramate—migraine	2.97e-05	0.000308	CcSEcCtD
Tramadol—Skin disorder—Gabapentin—migraine	2.96e-05	0.000308	CcSEcCtD
Tramadol—Insomnia—Timolol—migraine	2.96e-05	0.000307	CcSEcCtD
Tramadol—Hyperhidrosis—Gabapentin—migraine	2.95e-05	0.000306	CcSEcCtD
Tramadol—Tremor—Topiramate—migraine	2.95e-05	0.000306	CcSEcCtD
Tramadol—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	2.94e-05	0.000967	CbGpPWpGaD
Tramadol—Paraesthesia—Timolol—migraine	2.94e-05	0.000305	CcSEcCtD
Tramadol—OPRM1—Signaling by GPCR—HTR2B—migraine	2.93e-05	0.000963	CbGpPWpGaD
Tramadol—Urticaria—Valproic Acid—migraine	2.93e-05	0.000303	CcSEcCtD
Tramadol—Dyspnoea—Timolol—migraine	2.92e-05	0.000303	CcSEcCtD
Tramadol—Ill-defined disorder—Topiramate—migraine	2.92e-05	0.000303	CcSEcCtD
Tramadol—Somnolence—Timolol—migraine	2.91e-05	0.000302	CcSEcCtD
Tramadol—Abdominal pain—Valproic Acid—migraine	2.91e-05	0.000302	CcSEcCtD
Tramadol—Body temperature increased—Valproic Acid—migraine	2.91e-05	0.000302	CcSEcCtD
Tramadol—Anorexia—Gabapentin—migraine	2.91e-05	0.000302	CcSEcCtD
Tramadol—Anaemia—Topiramate—migraine	2.91e-05	0.000302	CcSEcCtD
Tramadol—HTR2C—GPCR ligand binding—EDNRA—migraine	2.89e-05	0.00095	CbGpPWpGaD
Tramadol—Agitation—Topiramate—migraine	2.89e-05	0.0003	CcSEcCtD
Tramadol—Dyspepsia—Timolol—migraine	2.89e-05	0.000299	CcSEcCtD
Tramadol—OPRD1—GPCR ligand binding—HTR2A—migraine	2.87e-05	0.000941	CbGpPWpGaD
Tramadol—Hypotension—Gabapentin—migraine	2.85e-05	0.000296	CcSEcCtD
Tramadol—Decreased appetite—Timolol—migraine	2.85e-05	0.000296	CcSEcCtD
Tramadol—OPRD1—GPCR downstream signaling—HTR1B—migraine	2.84e-05	0.000933	CbGpPWpGaD
Tramadol—Malaise—Topiramate—migraine	2.84e-05	0.000294	CcSEcCtD
Tramadol—Gastrointestinal disorder—Timolol—migraine	2.83e-05	0.000294	CcSEcCtD
Tramadol—Vertigo—Topiramate—migraine	2.83e-05	0.000293	CcSEcCtD
Tramadol—Fatigue—Timolol—migraine	2.83e-05	0.000293	CcSEcCtD
Tramadol—Syncope—Topiramate—migraine	2.82e-05	0.000293	CcSEcCtD
Tramadol—Pain—Timolol—migraine	2.8e-05	0.000291	CcSEcCtD
Tramadol—HTR2C—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	2.8e-05	0.000918	CbGpPWpGaD
Tramadol—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	2.79e-05	0.000916	CbGpPWpGaD
Tramadol—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—migraine	2.78e-05	0.000914	CbGpPWpGaD
Tramadol—HTR2C—GPCR ligand binding—CALCA—migraine	2.78e-05	0.000914	CbGpPWpGaD
Tramadol—Musculoskeletal discomfort—Gabapentin—migraine	2.78e-05	0.000288	CcSEcCtD
Tramadol—Palpitations—Topiramate—migraine	2.78e-05	0.000288	CcSEcCtD
Tramadol—HTR2C—GPCR downstream signaling—HTR2B—migraine	2.77e-05	0.000911	CbGpPWpGaD
Tramadol—Loss of consciousness—Topiramate—migraine	2.77e-05	0.000287	CcSEcCtD
Tramadol—Insomnia—Gabapentin—migraine	2.76e-05	0.000286	CcSEcCtD
Tramadol—CHRM3—GPCR ligand binding—HTR1B—migraine	2.75e-05	0.000904	CbGpPWpGaD
Tramadol—Cough—Topiramate—migraine	2.75e-05	0.000285	CcSEcCtD
Tramadol—Paraesthesia—Gabapentin—migraine	2.74e-05	0.000284	CcSEcCtD
Tramadol—OPRD1—GPCR downstream signaling—HTR1A—migraine	2.73e-05	0.000898	CbGpPWpGaD
Tramadol—Convulsion—Topiramate—migraine	2.73e-05	0.000283	CcSEcCtD
Tramadol—Dyspnoea—Gabapentin—migraine	2.72e-05	0.000282	CcSEcCtD
Tramadol—Hypertension—Topiramate—migraine	2.72e-05	0.000282	CcSEcCtD
Tramadol—Somnolence—Gabapentin—migraine	2.71e-05	0.000281	CcSEcCtD
Tramadol—Hypersensitivity—Valproic Acid—migraine	2.71e-05	0.000281	CcSEcCtD
Tramadol—HTR2C—Signaling by GPCR—HTR1D—migraine	2.71e-05	0.00089	CbGpPWpGaD
Tramadol—Feeling abnormal—Timolol—migraine	2.7e-05	0.00028	CcSEcCtD
Tramadol—OPRD1—GPCR downstream signaling—TAC1—migraine	2.69e-05	0.000884	CbGpPWpGaD
Tramadol—OPRD1—GPCR downstream signaling—NPS—migraine	2.69e-05	0.000884	CbGpPWpGaD
Tramadol—Dyspepsia—Gabapentin—migraine	2.69e-05	0.000279	CcSEcCtD
Tramadol—Gastrointestinal pain—Timolol—migraine	2.68e-05	0.000278	CcSEcCtD
Tramadol—Myalgia—Topiramate—migraine	2.68e-05	0.000278	CcSEcCtD
Tramadol—Chest pain—Topiramate—migraine	2.68e-05	0.000278	CcSEcCtD
Tramadol—Arthralgia—Topiramate—migraine	2.68e-05	0.000278	CcSEcCtD
Tramadol—Anxiety—Topiramate—migraine	2.67e-05	0.000277	CcSEcCtD
Tramadol—Unspecified disorder of skin and subcutaneous tissue—Topiramate—migraine	2.66e-05	0.000276	CcSEcCtD
Tramadol—Decreased appetite—Gabapentin—migraine	2.65e-05	0.000275	CcSEcCtD
Tramadol—CHRM3—GPCR ligand binding—HTR1A—migraine	2.65e-05	0.00087	CbGpPWpGaD
Tramadol—Discomfort—Topiramate—migraine	2.65e-05	0.000275	CcSEcCtD
Tramadol—Asthenia—Valproic Acid—migraine	2.64e-05	0.000274	CcSEcCtD
Tramadol—OPRD1—GPCR downstream signaling—HTR2C—migraine	2.64e-05	0.000867	CbGpPWpGaD
Tramadol—Gastrointestinal disorder—Gabapentin—migraine	2.64e-05	0.000273	CcSEcCtD
Tramadol—Fatigue—Gabapentin—migraine	2.63e-05	0.000273	CcSEcCtD
Tramadol—Dry mouth—Topiramate—migraine	2.62e-05	0.000272	CcSEcCtD
Tramadol—Constipation—Gabapentin—migraine	2.61e-05	0.000271	CcSEcCtD
Tramadol—Pain—Gabapentin—migraine	2.61e-05	0.000271	CcSEcCtD
Tramadol—CHRM3—GPCR ligand binding—TAC1—migraine	2.61e-05	0.000857	CbGpPWpGaD
Tramadol—CHRM3—GPCR ligand binding—NPS—migraine	2.61e-05	0.000857	CbGpPWpGaD
Tramadol—Pruritus—Valproic Acid—migraine	2.6e-05	0.00027	CcSEcCtD
Tramadol—Urticaria—Timolol—migraine	2.6e-05	0.00027	CcSEcCtD
Tramadol—HTR2C—GPCR ligand binding—HTR7—migraine	2.6e-05	0.000855	CbGpPWpGaD
Tramadol—SLC6A4—SIDS Susceptibility Pathways—TNF—migraine	2.59e-05	0.000852	CbGpPWpGaD
Tramadol—Abdominal pain—Timolol—migraine	2.59e-05	0.000269	CcSEcCtD
Tramadol—Body temperature increased—Timolol—migraine	2.59e-05	0.000269	CcSEcCtD
Tramadol—Confusional state—Topiramate—migraine	2.59e-05	0.000269	CcSEcCtD
Tramadol—OPRD1—Signaling by GPCR—HTR1B—migraine	2.58e-05	0.000847	CbGpPWpGaD
Tramadol—OPRD1—GPCR downstream signaling—EDNRA—migraine	2.57e-05	0.000843	CbGpPWpGaD
Tramadol—CHRM3—GPCR downstream signaling—HTR1D—migraine	2.57e-05	0.000843	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—CALCRL—migraine	2.56e-05	0.000842	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—RAMP1—migraine	2.56e-05	0.000842	CbGpPWpGaD
Tramadol—CHRM3—GPCR ligand binding—HTR2C—migraine	2.56e-05	0.000841	CbGpPWpGaD
Tramadol—Infection—Topiramate—migraine	2.55e-05	0.000265	CcSEcCtD
Tramadol—Shock—Topiramate—migraine	2.53e-05	0.000262	CcSEcCtD
Tramadol—Diarrhoea—Valproic Acid—migraine	2.52e-05	0.000261	CcSEcCtD
Tramadol—Nervous system disorder—Topiramate—migraine	2.52e-05	0.000261	CcSEcCtD
Tramadol—HTR2C—Signaling by GPCR—HTR2B—migraine	2.52e-05	0.000827	CbGpPWpGaD
Tramadol—Feeling abnormal—Gabapentin—migraine	2.52e-05	0.000261	CcSEcCtD
Tramadol—Thrombocytopenia—Topiramate—migraine	2.51e-05	0.000261	CcSEcCtD
Tramadol—OPRD1—Signaling Pathways—HTR1D—migraine	2.51e-05	0.000826	CbGpPWpGaD
Tramadol—OPRK1—GPCR ligand binding—HTR2A—migraine	2.51e-05	0.000825	CbGpPWpGaD
Tramadol—Tachycardia—Topiramate—migraine	2.51e-05	0.00026	CcSEcCtD
Tramadol—Gastrointestinal pain—Gabapentin—migraine	2.5e-05	0.000259	CcSEcCtD
Tramadol—Skin disorder—Topiramate—migraine	2.49e-05	0.000259	CcSEcCtD
Tramadol—OPRK1—GPCR downstream signaling—HTR1B—migraine	2.49e-05	0.000818	CbGpPWpGaD
Tramadol—CHRM3—GPCR ligand binding—EDNRA—migraine	2.49e-05	0.000818	CbGpPWpGaD
Tramadol—Hyperhidrosis—Topiramate—migraine	2.48e-05	0.000257	CcSEcCtD
Tramadol—OPRD1—Signaling by GPCR—HTR1A—migraine	2.48e-05	0.000815	CbGpPWpGaD
Tramadol—OPRD1—GPCR downstream signaling—CALCA—migraine	2.47e-05	0.000812	CbGpPWpGaD
Tramadol—Anorexia—Topiramate—migraine	2.45e-05	0.000254	CcSEcCtD
Tramadol—OPRD1—Signaling by GPCR—TAC1—migraine	2.44e-05	0.000803	CbGpPWpGaD
Tramadol—OPRD1—Signaling by GPCR—NPS—migraine	2.44e-05	0.000803	CbGpPWpGaD
Tramadol—Dizziness—Valproic Acid—migraine	2.43e-05	0.000253	CcSEcCtD
Tramadol—Urticaria—Gabapentin—migraine	2.42e-05	0.000252	CcSEcCtD
Tramadol—Hypersensitivity—Timolol—migraine	2.41e-05	0.00025	CcSEcCtD
Tramadol—Body temperature increased—Gabapentin—migraine	2.41e-05	0.00025	CcSEcCtD
Tramadol—Abdominal pain—Gabapentin—migraine	2.41e-05	0.00025	CcSEcCtD
Tramadol—CHRM3—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	2.41e-05	0.00079	CbGpPWpGaD
Tramadol—Hypotension—Topiramate—migraine	2.4e-05	0.000249	CcSEcCtD
Tramadol—OPRD1—Signaling by GPCR—HTR2C—migraine	2.4e-05	0.000787	CbGpPWpGaD
Tramadol—OPRK1—GPCR downstream signaling—HTR1A—migraine	2.4e-05	0.000787	CbGpPWpGaD
Tramadol—CHRM3—GPCR ligand binding—CALCA—migraine	2.4e-05	0.000787	CbGpPWpGaD
Tramadol—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	2.39e-05	0.000786	CbGpPWpGaD
Tramadol—CHRM3—GPCR downstream signaling—HTR2B—migraine	2.39e-05	0.000784	CbGpPWpGaD
Tramadol—OPRK1—GPCR downstream signaling—TAC1—migraine	2.36e-05	0.000775	CbGpPWpGaD
Tramadol—OPRK1—GPCR downstream signaling—NPS—migraine	2.36e-05	0.000775	CbGpPWpGaD
Tramadol—Asthenia—Timolol—migraine	2.35e-05	0.000244	CcSEcCtD
Tramadol—Vomiting—Valproic Acid—migraine	2.34e-05	0.000243	CcSEcCtD
Tramadol—Musculoskeletal discomfort—Topiramate—migraine	2.34e-05	0.000243	CcSEcCtD
Tramadol—OPRD1—Signaling Pathways—HTR2B—migraine	2.34e-05	0.000768	CbGpPWpGaD
Tramadol—OPRD1—Signaling by GPCR—EDNRA—migraine	2.33e-05	0.000766	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—HTR1D—migraine	2.33e-05	0.000766	CbGpPWpGaD
Tramadol—Insomnia—Topiramate—migraine	2.32e-05	0.000241	CcSEcCtD
Tramadol—Rash—Valproic Acid—migraine	2.32e-05	0.000241	CcSEcCtD
Tramadol—Dermatitis—Valproic Acid—migraine	2.32e-05	0.000241	CcSEcCtD
Tramadol—Pruritus—Timolol—migraine	2.32e-05	0.000241	CcSEcCtD
Tramadol—OPRK1—GPCR downstream signaling—HTR2C—migraine	2.31e-05	0.00076	CbGpPWpGaD
Tramadol—OPRD1—GPCR downstream signaling—HTR7—migraine	2.31e-05	0.000759	CbGpPWpGaD
Tramadol—Headache—Valproic Acid—migraine	2.31e-05	0.000239	CcSEcCtD
Tramadol—Paraesthesia—Topiramate—migraine	2.31e-05	0.000239	CcSEcCtD
Tramadol—Dyspnoea—Topiramate—migraine	2.29e-05	0.000237	CcSEcCtD
Tramadol—Somnolence—Topiramate—migraine	2.28e-05	0.000237	CcSEcCtD
Tramadol—OPRK1—Signaling by GPCR—HTR1B—migraine	2.26e-05	0.000743	CbGpPWpGaD
Tramadol—Dyspepsia—Topiramate—migraine	2.26e-05	0.000234	CcSEcCtD
Tramadol—OPRK1—GPCR downstream signaling—EDNRA—migraine	2.25e-05	0.00074	CbGpPWpGaD
Tramadol—Hypersensitivity—Gabapentin—migraine	2.25e-05	0.000233	CcSEcCtD
Tramadol—OPRD1—Signaling by GPCR—CALCA—migraine	2.24e-05	0.000737	CbGpPWpGaD
Tramadol—Diarrhoea—Timolol—migraine	2.24e-05	0.000233	CcSEcCtD
Tramadol—CHRM3—GPCR ligand binding—HTR7—migraine	2.24e-05	0.000736	CbGpPWpGaD
Tramadol—Decreased appetite—Topiramate—migraine	2.23e-05	0.000232	CcSEcCtD
Tramadol—Gastrointestinal disorder—Topiramate—migraine	2.22e-05	0.00023	CcSEcCtD
Tramadol—Fatigue—Topiramate—migraine	2.21e-05	0.00023	CcSEcCtD
Tramadol—OPRK1—Signaling Pathways—HTR1D—migraine	2.2e-05	0.000724	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—CALCRL—migraine	2.2e-05	0.000723	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—RAMP1—migraine	2.2e-05	0.000723	CbGpPWpGaD
Tramadol—Pain—Topiramate—migraine	2.2e-05	0.000228	CcSEcCtD
Tramadol—Constipation—Topiramate—migraine	2.2e-05	0.000228	CcSEcCtD
Tramadol—Asthenia—Gabapentin—migraine	2.19e-05	0.000227	CcSEcCtD
Tramadol—Nausea—Valproic Acid—migraine	2.19e-05	0.000227	CcSEcCtD
Tramadol—OPRK1—Signaling by GPCR—HTR1A—migraine	2.18e-05	0.000715	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—HTR2B—migraine	2.17e-05	0.000712	CbGpPWpGaD
Tramadol—OPRK1—GPCR downstream signaling—CALCA—migraine	2.17e-05	0.000712	CbGpPWpGaD
Tramadol—Dizziness—Timolol—migraine	2.17e-05	0.000225	CcSEcCtD
Tramadol—Pruritus—Gabapentin—migraine	2.16e-05	0.000224	CcSEcCtD
Tramadol—OPRK1—Signaling by GPCR—NPS—migraine	2.14e-05	0.000704	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—TAC1—migraine	2.14e-05	0.000704	CbGpPWpGaD
Tramadol—OPRM1—GPCR ligand binding—HTR2A—migraine	2.12e-05	0.000697	CbGpPWpGaD
Tramadol—Feeling abnormal—Topiramate—migraine	2.12e-05	0.000219	CcSEcCtD
Tramadol—OPRM1—GPCR downstream signaling—HTR1B—migraine	2.1e-05	0.000691	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—HTR2C—migraine	2.1e-05	0.00069	CbGpPWpGaD
Tramadol—Gastrointestinal pain—Topiramate—migraine	2.1e-05	0.000218	CcSEcCtD
Tramadol—OPRD1—Signaling by GPCR—HTR7—migraine	2.1e-05	0.00069	CbGpPWpGaD
Tramadol—Diarrhoea—Gabapentin—migraine	2.09e-05	0.000217	CcSEcCtD
Tramadol—Vomiting—Timolol—migraine	2.08e-05	0.000216	CcSEcCtD
Tramadol—Rash—Timolol—migraine	2.07e-05	0.000214	CcSEcCtD
Tramadol—Dermatitis—Timolol—migraine	2.06e-05	0.000214	CcSEcCtD
Tramadol—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	2.06e-05	0.000677	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—LRP1—migraine	2.06e-05	0.000676	CbGpPWpGaD
Tramadol—Headache—Timolol—migraine	2.05e-05	0.000213	CcSEcCtD
Tramadol—OPRK1—Signaling Pathways—HTR2B—migraine	2.05e-05	0.000673	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—EDNRA—migraine	2.04e-05	0.000672	CbGpPWpGaD
Tramadol—Urticaria—Topiramate—migraine	2.04e-05	0.000212	CcSEcCtD
Tramadol—Abdominal pain—Topiramate—migraine	2.03e-05	0.000211	CcSEcCtD
Tramadol—Body temperature increased—Topiramate—migraine	2.03e-05	0.000211	CcSEcCtD
Tramadol—OPRK1—GPCR downstream signaling—HTR7—migraine	2.03e-05	0.000666	CbGpPWpGaD
Tramadol—OPRM1—GPCR downstream signaling—HTR1A—migraine	2.03e-05	0.000665	CbGpPWpGaD
Tramadol—Dizziness—Gabapentin—migraine	2.02e-05	0.000209	CcSEcCtD
Tramadol—OPRM1—GPCR downstream signaling—TAC1—migraine	1.99e-05	0.000655	CbGpPWpGaD
Tramadol—OPRM1—GPCR downstream signaling—NPS—migraine	1.99e-05	0.000655	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—CALCA—migraine	1.97e-05	0.000646	CbGpPWpGaD
Tramadol—OPRM1—GPCR downstream signaling—HTR2C—migraine	1.96e-05	0.000642	CbGpPWpGaD
Tramadol—Nausea—Timolol—migraine	1.95e-05	0.000202	CcSEcCtD
Tramadol—Vomiting—Gabapentin—migraine	1.94e-05	0.000201	CcSEcCtD
Tramadol—Rash—Gabapentin—migraine	1.92e-05	0.0002	CcSEcCtD
Tramadol—Dermatitis—Gabapentin—migraine	1.92e-05	0.000199	CcSEcCtD
Tramadol—Headache—Gabapentin—migraine	1.91e-05	0.000198	CcSEcCtD
Tramadol—OPRM1—Signaling by GPCR—HTR1B—migraine	1.91e-05	0.000628	CbGpPWpGaD
Tramadol—OPRM1—GPCR downstream signaling—EDNRA—migraine	1.9e-05	0.000625	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—CALCRL—migraine	1.9e-05	0.000623	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—RAMP1—migraine	1.9e-05	0.000623	CbGpPWpGaD
Tramadol—Hypersensitivity—Topiramate—migraine	1.89e-05	0.000196	CcSEcCtD
Tramadol—OPRM1—Signaling Pathways—HTR1D—migraine	1.86e-05	0.000612	CbGpPWpGaD
Tramadol—Asthenia—Topiramate—migraine	1.84e-05	0.000191	CcSEcCtD
Tramadol—OPRK1—Signaling by GPCR—HTR7—migraine	1.84e-05	0.000605	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—HTR1A—migraine	1.84e-05	0.000604	CbGpPWpGaD
Tramadol—OPRM1—GPCR downstream signaling—CALCA—migraine	1.83e-05	0.000602	CbGpPWpGaD
Tramadol—HTR2C—GPCR ligand binding—HTR2A—migraine	1.82e-05	0.000599	CbGpPWpGaD
Tramadol—Pruritus—Topiramate—migraine	1.82e-05	0.000188	CcSEcCtD
Tramadol—Nausea—Gabapentin—migraine	1.81e-05	0.000188	CcSEcCtD
Tramadol—OPRM1—Signaling by GPCR—NPS—migraine	1.81e-05	0.000595	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—TAC1—migraine	1.81e-05	0.000595	CbGpPWpGaD
Tramadol—HTR2C—GPCR downstream signaling—HTR1B—migraine	1.81e-05	0.000593	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—LRP1—migraine	1.8e-05	0.000593	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—HTR2C—migraine	1.78e-05	0.000583	CbGpPWpGaD
Tramadol—Diarrhoea—Topiramate—migraine	1.76e-05	0.000182	CcSEcCtD
Tramadol—HTR2C—GPCR downstream signaling—HTR1A—migraine	1.74e-05	0.000571	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—HTR2B—migraine	1.73e-05	0.000569	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—EDNRA—migraine	1.73e-05	0.000568	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—CACNA1A—migraine	1.72e-05	0.000564	CbGpPWpGaD
Tramadol—OPRM1—GPCR downstream signaling—HTR7—migraine	1.71e-05	0.000563	CbGpPWpGaD
Tramadol—HTR2C—GPCR downstream signaling—NPS—migraine	1.71e-05	0.000563	CbGpPWpGaD
Tramadol—HTR2C—GPCR downstream signaling—TAC1—migraine	1.71e-05	0.000563	CbGpPWpGaD
Tramadol—Dizziness—Topiramate—migraine	1.7e-05	0.000176	CcSEcCtD
Tramadol—OPRM1—Signaling by GPCR—CALCA—migraine	1.66e-05	0.000546	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—HTR1B—migraine	1.64e-05	0.000539	CbGpPWpGaD
Tramadol—HTR2C—GPCR downstream signaling—EDNRA—migraine	1.63e-05	0.000537	CbGpPWpGaD
Tramadol—Vomiting—Topiramate—migraine	1.63e-05	0.000169	CcSEcCtD
Tramadol—OPRD1—GPCR downstream signaling—HTR2A—migraine	1.62e-05	0.000532	CbGpPWpGaD
Tramadol—Rash—Topiramate—migraine	1.62e-05	0.000168	CcSEcCtD
Tramadol—Dermatitis—Topiramate—migraine	1.62e-05	0.000168	CcSEcCtD
Tramadol—Headache—Topiramate—migraine	1.61e-05	0.000167	CcSEcCtD
Tramadol—HTR2C—Signaling Pathways—HTR1D—migraine	1.6e-05	0.000525	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—HTR1A—migraine	1.58e-05	0.000519	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—NOTCH4—migraine	1.58e-05	0.000519	CbGpPWpGaD
Tramadol—HTR2C—GPCR downstream signaling—CALCA—migraine	1.57e-05	0.000517	CbGpPWpGaD
Tramadol—CHRM3—GPCR ligand binding—HTR2A—migraine	1.57e-05	0.000516	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—HTR7—migraine	1.56e-05	0.000511	CbGpPWpGaD
Tramadol—CHRM3—GPCR downstream signaling—HTR1B—migraine	1.56e-05	0.000511	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—TAC1—migraine	1.56e-05	0.000511	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—NPS—migraine	1.56e-05	0.000511	CbGpPWpGaD
Tramadol—Nausea—Topiramate—migraine	1.53e-05	0.000158	CcSEcCtD
Tramadol—OPRM1—Signaling Pathways—LRP1—migraine	1.53e-05	0.000501	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—HTR1B—migraine	1.52e-05	0.0005	CbGpPWpGaD
Tramadol—CHRM3—GPCR downstream signaling—HTR1A—migraine	1.5e-05	0.000492	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—HTR2B—migraine	1.49e-05	0.000489	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—EDNRA—migraine	1.48e-05	0.000487	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—CACNA1A—migraine	1.48e-05	0.000485	CbGpPWpGaD
Tramadol—CHRM3—GPCR downstream signaling—TAC1—migraine	1.47e-05	0.000484	CbGpPWpGaD
Tramadol—CHRM3—GPCR downstream signaling—NPS—migraine	1.47e-05	0.000484	CbGpPWpGaD
Tramadol—HTR2C—GPCR downstream signaling—HTR7—migraine	1.47e-05	0.000483	CbGpPWpGaD
Tramadol—OPRD1—Signaling by GPCR—HTR2A—migraine	1.47e-05	0.000483	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—HTR1A—migraine	1.47e-05	0.000482	CbGpPWpGaD
Tramadol—CHRM3—GPCR downstream signaling—HTR2C—migraine	1.45e-05	0.000475	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—TAC1—migraine	1.44e-05	0.000474	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—PGR—migraine	1.44e-05	0.000474	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—NPS—migraine	1.44e-05	0.000474	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—CALCA—migraine	1.43e-05	0.000469	CbGpPWpGaD
Tramadol—OPRK1—GPCR downstream signaling—HTR2A—migraine	1.42e-05	0.000466	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—HTR2C—migraine	1.42e-05	0.000465	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—HTR1B—migraine	1.41e-05	0.000464	CbGpPWpGaD
Tramadol—CHRM3—GPCR downstream signaling—EDNRA—migraine	1.41e-05	0.000462	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—NOTCH4—migraine	1.38e-05	0.000455	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—HTR1D—migraine	1.38e-05	0.000452	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—EDNRA—migraine	1.38e-05	0.000452	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—HTR1A—migraine	1.36e-05	0.000447	CbGpPWpGaD
Tramadol—CHRM3—GPCR downstream signaling—CALCA—migraine	1.35e-05	0.000445	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—NOTCH3—migraine	1.34e-05	0.000441	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—TAC1—migraine	1.34e-05	0.00044	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—NPS—migraine	1.34e-05	0.00044	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—HTR7—migraine	1.34e-05	0.000439	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—HTR1B—migraine	1.34e-05	0.000439	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—CALCA—migraine	1.33e-05	0.000435	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—HTR2C—migraine	1.31e-05	0.000431	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—LRP1—migraine	1.31e-05	0.00043	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—HTR2A—migraine	1.29e-05	0.000423	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—HTR1A—migraine	1.29e-05	0.000422	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—HTR2B—migraine	1.28e-05	0.000421	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—EDNRA—migraine	1.28e-05	0.00042	CbGpPWpGaD
Tramadol—CHRM3—GPCR downstream signaling—HTR7—migraine	1.27e-05	0.000416	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—NPS—migraine	1.27e-05	0.000416	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—PGR—migraine	1.27e-05	0.000416	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—TAC1—migraine	1.27e-05	0.000416	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—HTR2C—migraine	1.24e-05	0.000408	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—HTR7—migraine	1.24e-05	0.000407	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—CALCA—migraine	1.23e-05	0.000404	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—EDNRA—migraine	1.21e-05	0.000397	CbGpPWpGaD
Tramadol—OPRM1—GPCR downstream signaling—HTR2A—migraine	1.2e-05	0.000394	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—NOTCH3—migraine	1.18e-05	0.000387	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—NOTCH4—migraine	1.17e-05	0.000384	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—CALCA—migraine	1.16e-05	0.000382	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—HTR7—migraine	1.15e-05	0.000378	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—HTR1B—migraine	1.13e-05	0.000371	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—LRP1—migraine	1.13e-05	0.00037	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—HTR2A—migraine	1.09e-05	0.000358	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—HTR7—migraine	1.09e-05	0.000357	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—HTR1A—migraine	1.09e-05	0.000357	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—NPS—migraine	1.07e-05	0.000351	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—TAC1—migraine	1.07e-05	0.000351	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—PGR—migraine	1.07e-05	0.000351	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—TGFBR2—migraine	1.07e-05	0.000351	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—HTR2C—migraine	1.05e-05	0.000345	CbGpPWpGaD
Tramadol—HTR2C—GPCR downstream signaling—HTR2A—migraine	1.03e-05	0.000338	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—CACNA1A—migraine	1.03e-05	0.000337	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—EDNRA—migraine	1.02e-05	0.000335	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—NOTCH4—migraine	1e-05	0.00033	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—NOTCH3—migraine	9.95e-06	0.000327	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—CALCA—migraine	9.83e-06	0.000323	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—HTR1B—migraine	9.69e-06	0.000318	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—TGFBR2—migraine	9.37e-06	0.000308	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—HTR2A—migraine	9.36e-06	0.000307	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—HTR1A—migraine	9.33e-06	0.000306	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—HTR7—migraine	9.19e-06	0.000302	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—TAC1—migraine	9.19e-06	0.000302	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—NPS—migraine	9.19e-06	0.000302	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—PGR—migraine	9.19e-06	0.000302	CbGpPWpGaD
Tramadol—CHRM3—GPCR downstream signaling—HTR2A—migraine	8.87e-06	0.000291	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—EDNRA—migraine	8.77e-06	0.000288	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—HTR2A—migraine	8.69e-06	0.000285	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—NOTCH4—migraine	8.65e-06	0.000284	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—NOTCH3—migraine	8.54e-06	0.000281	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—CALCA—migraine	8.44e-06	0.000277	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—HTR1B—migraine	8.35e-06	0.000274	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—HTR2A—migraine	8.06e-06	0.000265	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—HTR1A—migraine	8.03e-06	0.000264	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—TGFBR2—migraine	7.92e-06	0.00026	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—TAC1—migraine	7.91e-06	0.00026	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—NPS—migraine	7.91e-06	0.00026	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—PGR—migraine	7.91e-06	0.00026	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—HTR7—migraine	7.89e-06	0.000259	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—HTR2C—migraine	7.76e-06	0.000255	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—ESR1—migraine	7.71e-06	0.000253	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—HTR2A—migraine	7.62e-06	0.00025	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—EDNRA—migraine	7.55e-06	0.000248	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—NOTCH3—migraine	7.36e-06	0.000242	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—CALCA—migraine	7.27e-06	0.000239	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—TGFBR2—migraine	6.8e-06	0.000223	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—HTR7—migraine	6.8e-06	0.000223	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—ESR1—migraine	6.76e-06	0.000222	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—CACNA1A—migraine	6.72e-06	0.000221	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—HTR2A—migraine	6.44e-06	0.000211	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—TGFBR2—migraine	5.85e-06	0.000192	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—ESR1—migraine	5.71e-06	0.000188	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—MTHFR—migraine	5.68e-06	0.000187	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—HTR2A—migraine	5.53e-06	0.000182	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—ESR1—migraine	4.91e-06	0.000161	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—MTHFR—migraine	4.89e-06	0.000161	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—HTR2A—migraine	4.76e-06	0.000156	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—ESR1—migraine	4.22e-06	0.000139	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—MTHFR—migraine	3.4e-06	0.000112	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—MTHFR—migraine	2.22e-06	7.3e-05	CbGpPWpGaD
